Navigation Links
New and revised standards for omega-3s, natural sweeteners and other food ingredients proposed
Date:1/2/2013

rred from advancement into final monograph status based on public comments received that indicated the monograph needed to be strengthened with quantitative test requirements for phospholipids. Phospholipids are important biological chemicalsand krill phospholipids contain the omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). Considerable outside research is being conducted on these types of phospholipids and their potential health benefits in the areas of heart and cardiovascular health, joint health, women's health and brain health. Many of these purported benefits are associated with the specific DHA and EPA fatty acids that are attached to phospholipids in krill oil. The revised version of this monograph, reflective of comments received, proposes both qualitative (fingerprint) and quantitative tests for total phospholipid content as well as one of the key phospholipidsphosphatidylcholinewhich is believed to be linked to certain health benefits.

  • Steviol GlyosidesFirst proposed in the December 2011 FCC Forum, a revised new monograph proposal incorporating comments and suggestions from stakeholders for the naturally derived sweetener provides a more simplified approach for separating and measuring all nine glycosides present in the stevia leaf. USP also has a monograph for high purity Rebaudioside A, the first stevia-based sweetener widely used in the United States and Europe. A range of steviol glycosides, including mixtures of different glycosides, are now being used in a variety of products in addition to Rebaudioside A. For regulatory compliance, formulation considerations (e.g., different glycosides may have different sweetener profiles) and other reasons, it is critical for manufacturers to be able to accurately identify the material they have sourced. According to the International Stevia Council, more than 56 million households in the United States have stevia and stevia-sweetened products in their homes. The new F
    '/>"/>

  • Contact: Francine Pierson
    fp@usp.org
    301-816-8588
    US Pharmacopeia
    Source:Eurekalert

    Page: 1 2 3

    Related biology news :

    1. Modern Mobility Aids, Inc. Announces a Revised Agreement for the Acquisition of Lumigene
    2. American Meteorological Society releases revised climate change statement
    3. Global Surgical Devices Market Growth Driven by Improving Standards of Living and Longer Life Expectancies, Research Shows
    4. Poll shows strong voter support for school nutrition standards
    5. Caution needed with new greenhouse gas emission standards
    6. NIST focuses on testing standards to support lab on a chip commercialization
    7. Entrust to Address Attendees, Exhibit at ICAO Eighth Symposium and Exhibition on MRTDs, Biometrics and Security Standards
    8. Reducing radiation: Heart Institute model shows hope for new standards worldwide
    9. Biology professor secures grant to save West Virginias primary natural history collection
    10. Validity CTO to Present Natural ID Solutions for Improving Mobile Risk Management and User Experience at NFC Solutions Summit 2012
    11. Honoring the fundamental role of microbes in the natural history of our planet
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/18/2015)... , Feb. 18, 2015  Cepheid (NASDAQ: ... at the following conferences, and invited investors to participate via ... Boston, MA Tuesday, March 3, 2015 at ... Conference, Orlando, FL Wednesday, March 4, ... Webcasts To access the live webcasts for these events, please ...
    (Date:2/11/2015)... February 11, 2015 ... "Access Control Market by Product (Cards and Readers, Biometrics, ... Defense, Government, Industrial, Healthcare, Education) and By Geography - Global ... MarketsandMarkets, the Access Control Market is expected ... at a CAGR of 10.6% between 2014 ...
    (Date:2/5/2015)... 2015  Marken is starting its 35 th ... a new marketing campaign to solidify its place as ... campaign focuses on First as a primary ... The first headline in the series, ... its client,s priorities. Marken recognizes the need to protect ...
    Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2
    ... The ongoing dance between a virus and ... human adenoviruses typically cause mild infections, recent reports have ... fatal, human infections. Researchers from the Massachusetts ... for Public Health, School of Systems Biology, George Mason ...
    ... balls that can zap pain and lung tumors to ... physicians will present the latest research on cutting-edge treatments ... Meeting April 13󈝾 at the Ernest N. Morial Convention ... the theme "IR Reaching Out" and delivers education, resources ...
    ... have identified a new potential therapeutic target for lowering ... to statins. Scientists in the lab of ... action of a gene responsible for transporting a protein ... remove cholesterol from the blood in mice. Trapping the ...
    Cached Biology News:Society of Interventional Radiology: 38th Annual Scientific Meeting 2U-M researchers find new way to clear cholesterol from the blood 2
    (Date:3/2/2015)... , March 2, 2015  Pfenex Inc. (NYSE ... the development of biosimilar therapeutics, today announced that ... Global Healthcare Conference in Miami, FL at the Loews Miami ... executive officer of Pfenex, will provide an overview ... on March 12th at 9:00 am ET. A live audio webcast ...
    (Date:3/2/2015)... YORK , March 2, 2015 ... scroll to bottom.   Moments ago, Analysts ... including Sunshine Heart (NASDAQ: SSH ), ... ), Syneron Medical (NASDAQ: ELOS ), Spectranetics (NASDAQ: ... ). Analysts Review provides a single unified platform for investors, ...
    (Date:3/2/2015)... , March 2, 2015 VG ... developing therapies for autoimmune and infectious diseases, announced ... has issued an important new composition of matter ... through the targeting of CLIP. ... technology underlying VG Life Sciences, VG1177, a synthetic ...
    (Date:3/2/2015)... March 02, 2015 Global ... formed alliance with Shenzhen HANK Bioengineering Co., Ltd. ... The alliance will establish a stem cells training ... China in September 2015. , Shenzhen HANK is ... an award-winning scientist, microbiologist and virologist, to integrate ...
    Breaking Biology Technology:Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 2Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 3Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 4VG Life Sciences Granted Key Composition Of Matter Patent 2VG Life Sciences Granted Key Composition Of Matter Patent 3Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3
    ... Avastin(R) May Slow Tumor Growth, ROCKVILLE, ... ENMD ), a clinical-stage pharmaceutical company developing,therapeutics ... diseases, today,announced the presentation of interim results ... NCD with Avastin(R) (bevacizumab) in patients,with advanced ...
    ... Sanofi-aventis announced,today that the anticoagulant Clexane(R) (enoxaparin ... Japan by the Ministry of Health, Labour ... (VTE) in patients,undergoing orthopaedic surgery of the ... knee replacement and hip fracture surgery., ...
    ... Forest Laboratories, Inc.,(NYSE: FRX ), Forest Laboratories ... Merz Pharmaceuticals GmbH announced that they have filed ... the District of Delaware against,additional companies for infringement ... relates to Forest,s Namenda(R) product. The defendants,named in ...
    Cached Biology Technology:EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study 2EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study 3EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study 4Clexane(R)/Lovenox(R) Approved in Japan 2Clexane(R)/Lovenox(R) Approved in Japan 3Clexane(R)/Lovenox(R) Approved in Japan 4Clexane(R)/Lovenox(R) Approved in Japan 5Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringement 2
    Cag-A (IgG) -Ab EIA Sample Size: 10 l...
    ... Inhibitor is a potent noncompetitive ... as RNase A. Like other ... Inhibitor is an acidic protein ... kDa. RNaseOUT inhibits RNase A ...
    ... Inhibitor (Ribonuclease inhibitor) is a ... to inhibit RNase activity. It ... endonuclease activity. , Inhibits ... RNA template , Lacks ...
    Canine Aortic Smooth Muscle Cells (CnAOSMC) (>500,000 cells)...
    Biology Products: